These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 10644076)

  • 21. Influence of pH on in vitro disintegration of phosphate binders.
    Stamatakis MK; Alderman JM; Meyer-Stout PJ
    Am J Kidney Dis; 1998 Nov; 32(5):808-12. PubMed ID: 9820451
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vitro bioequivalence study of nine brands of artesunate tablets marketed in Nigeria.
    Esimone CO; Okoye FB; Onah BU; Nworu CS; Omeje EO
    J Vector Borne Dis; 2008 Mar; 45(1):60-5. PubMed ID: 18399319
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Is there variability in drug release and physical characteristics of amiodarone chloride from different commercially available tablets? Possible therapeutic implications.
    Ngo SN; Barnes T
    Int J Pharm Pract; 2010 Aug; 18(4):245-8. PubMed ID: 20636678
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The bioinequivalence of carbamazepine tablets with a history of clinical failures.
    Meyer MC; Straughn AB; Jarvi EJ; Wood GC; Pelsor FR; Shah VP
    Pharm Res; 1992 Dec; 9(12):1612-6. PubMed ID: 1488405
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The chemical and pharmaceutical equivalence of sulphadoxine/pyrimethamine tablets sold on the Tanzanian market.
    Hebron Y; Tettey JN; Pournamdari M; Watson DG
    J Clin Pharm Ther; 2005 Dec; 30(6):575-81. PubMed ID: 16336290
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diclofenac sodium multisource prolonged release tablets--a comparative study on the dissolution profiles.
    Bertocchi P; Antoniella E; Valvo L; Alimonti S; Memoli A
    J Pharm Biomed Anal; 2005 Apr; 37(4):679-85. PubMed ID: 15797788
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Consumer vinegar test for determining calcium disintegration.
    Mason NA; Patel JD; Dressman JB; Shimp LA
    Am J Hosp Pharm; 1992 Sep; 49(9):2218-22. PubMed ID: 1524066
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Re-evaluation of in vitro dissolution techniques for supersaturating drug delivery systems.
    Bagchi S; Mukherjee T; Plakogiannis F
    Pharm Dev Technol; 2012; 17(4):477-82. PubMed ID: 21284575
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro disintegration studies of weekly generic and branded risedronate sodium formulations available in Canada.
    Walker AD; Adachi JD
    Curr Med Res Opin; 2011 Sep; 27(9):1749-54. PubMed ID: 21781014
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Preparation, physicochemical characterization and drug release studies of albendazole solid dispersions.
    Mallick S; Sahoo A; Mitra SS
    Boll Chim Farm; 2003 May; 142(4):180-6. PubMed ID: 12918228
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Formulation development of chewable albendazole tablets with improved dissolution rate.
    Kimaro E; Tibalinda P; Shedafa R; Temu M; Kaale E
    Heliyon; 2019 Dec; 5(12):e02911. PubMed ID: 31890938
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An investigation of the disintegration of tablets in biorelevant media.
    Anwar S; Fell JT; Dickinson PA
    Int J Pharm; 2005 Feb; 290(1-2):121-7. PubMed ID: 15664137
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Disintegration of sublingual tablets: proposal for a validated test method and acceptance criterion.
    Weda M; van Riet-Nales DA; van Aalst P; de Kaste D; Lekkerkerker JF
    Pharmeur Sci Notes; 2006 Dec; 2006(2):41-4. PubMed ID: 17691213
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Guar gum as a carrier for colon specific delivery; influence of metronidazole and tinidazole on in vitro release of albendazole from guar gum matrix tablets.
    Krishnaiah YS; Seetha Devi A; Nageswara Rao L; Bhaskar Reddy PR; Karthikeyan RS; Satyanarayana V
    J Pharm Pharm Sci; 2001; 4(3):235-43. PubMed ID: 11737989
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Complexation and solubility behavior of albendazole with some cyclodextrins.
    Díaz D; Bernad Bernad MJ; Gracia Mora J; Escobar Llanos CM
    Pharm Dev Technol; 1998 Aug; 3(3):395-403. PubMed ID: 9742560
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Technological and pharmacotherapeutic properties of selected drugs with modified release of diclofenac sodium].
    Kołodziejczyk MK; Kołodziejska J; Zgoda MM
    Polim Med; 2012; 42(2):121-32. PubMed ID: 23016443
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of Dissolution Profile between Original and Generic Products of Zolpidem Tartrate by Microdialysis-HPLC.
    Inaba K; Oie T; Otake H; Kotake T; Nagai N
    Chem Pharm Bull (Tokyo); 2019; 67(2):120-124. PubMed ID: 30713271
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The use of natural and synthetic hydrophilic polymers in the formulation of metformin hydrochloride tablets with different profile release].
    Kołodziejczyk MK; Kołodziejska J; Zgoda MM
    Polim Med; 2012; 42(3-4):167-84. PubMed ID: 23457958
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of surfactants in the release of very slightly soluble drugs from tablets.
    Schott H; Kwan LC; Feldman S
    J Pharm Sci; 1982 Sep; 71(9):1038-45. PubMed ID: 7131271
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparative studies on the in vitro drug dissolution profiles for hydroxyzine hydrochloride tablets.
    Loucas SP; Maager P; Mehl B
    Ann Pharmacother; 1993 Jan; 27(1):13-8. PubMed ID: 8431611
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.